IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN ECUADOR

被引：0
作者：
Lopez-Cabra, C. [1 ]
Rodriguez, A. D. [2 ]
Mogollon, Mayorga W. [2 ]
Chavez, M. A. [3 ]
Patino, A. [3 ]
Herran, S. E. [1 ]
Marrugo, R. [1 ]
机构：
[1] Bayer, Bogota, Cun, Colombia
[2] Numeris, Bogota, Colombia
[3] Bayer, San Jose, Cun, Costa Rica
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE196
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [41] Pharmacotherapy considerations with finerenone in the treatment of chronic kidney disease associated with type 2 diabetes
    Ashjian, Emily
    Clarke, Megan
    Pogue, Kristen
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2023, 80 (23) : 1708 - 1721
  • [42] Blood pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes
    Ruilope, Luis M.
    Agarwal, Rajiv
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Rossing, Peter
    Sarafidis, Pantelis
    Schmieder, Roland E.
    Joseph, Amer
    Rethemeier, Nicole
    Nowack, Christina
    Bakris, George L.
    [J]. HYPERTENSION, 2022, 79 (12) : 2685 - 2695
  • [43] sRAGE-A Biomarker of Kidney Disease in Youth-Onset Type 2 Diabetes (T2D)
    Bacha, Fida
    Urbina, Elaine M.
    Gidding, Samuel
    Monnier, Vincent M.
    El Ghormli, Laure
    Drews, Kimberly
    Braffett, Barbara H.
    [J]. DIABETES, 2023, 72
  • [44] ECONOMIC BURDEN OF MODERATE CHRONIC KIDNEY DISEASE IN TYPE 2 DIABETES
    McQueen, R. B.
    Farahbakhshian, S.
    Bell, K.
    Nair, K.
    Saseen, J.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A14 - A14
  • [45] ECONOMIC BURDEN OF CHRONIC KIDNEY DISEASE WITH TYPE 2 DIABETES IN TURKIYE
    Kurnaz, M.
    Yildiz, A.
    Oguz, A.
    Turkmen, E.
    Karatas, A.
    Buyukisik, T.
    Ozturk, F.
    Okcun, S.
    Erkut, Y.
    Kockaya, G.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S163 - S163
  • [46] Diabetes Educators: Understanding the Role of Finerenone in Chronic Kidney Disease Associated with Type 2 Diabetes Mellitus
    Kome, Anne M.
    Yang, Anita
    Gee, Patrick
    Klein, Klara R.
    [J]. DIABETES THERAPY, 2025, : 763 - 784
  • [47] Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone
    Agarwal, Rajiv
    Pitt, Bertram
    Rossing, Peter
    Anker, Stefan D.
    Filippatos, Gerasimos
    Ruilope, Luis M.
    Kovesdy, Csaba P.
    Tuttle, Katherine
    Vaduganathan, Muthiah
    Wanner, Christoph
    Bansilal, Sameer
    Gebel, Martin
    Joseph, Amer
    Lawatscheck, Robert
    Bakris, George L.
    [J]. JAMA CARDIOLOGY, 2023, 8 (08) : 732 - 741
  • [48] Validation of the FINE-CKD Model for Future Health Technology Assessments for Finerenone in Patients With Chronic Kidney Disease And Type 2 Diabetes
    Pochopien, Michal
    Cherney, David
    Drzewiecka, Aleksandra
    Folkerts, Kerstin
    Levy, Pierre
    Millier, Aurelie
    Morris, Stephen
    Palarczyk, Monika
    Roy-Chaudhury, Prabir
    Sullivan, Sean D.
    Mernagh, Paul
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2022, 28 (06) : S104 - S111
  • [49] FINERENONE AND CHRONIC KIDNEY DISEASE OUTCOMES IN HISPANIC PATIENTS WITH TYPE 2 DIABETES: A FIDELITY ANALYSIS
    Rosas, Sylvia
    Ruilope, Luis M.
    Anker, Stefan D.
    Pitt, Bertram
    Rossing, Peter
    Bonfanti, Andres A. C.
    Correa-Rotter, Ricardo
    Gonzalez, Fernando
    Pergola, Pablo
    Umpierrez, Guillermo
    Scalise, Andrea
    Scott, Charlie
    Joseph, Amer
    Bakris, George L.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (04) : S47 - S48
  • [50] FINERENONE AND CHRONIC KIDNEY DISEASE OUTCOMES IN BLACK PATIENTS WITH TYPE 2 DIABETES: A FIDELITY ANALYSIS
    Flack, John M.
    Agarwal, Rajiv
    Anker, Stefan D.
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Alder, Sharon
    Fried, Linda
    Jamerson, Kenneth
    Toto, Robert
    Brinker, Meike
    Farjat, Alfredo E.
    Kolkhof, Peter
    Joseph, Amer
    Bakris, George
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (04) : S20 - S20
12345